SNDX240920C17500
- 2.67
- 0.000.00%
Syndax Pharmaceuticals Newsroom
We Think Syndax Pharmaceuticals (NASDAQ:SNDX) Needs To Drive Business Growth Carefully
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals, Inc. (SNDX): This Small-Cap Healthcare Stock Is A Good Buy Right Now
Foundation Medicine Partners With Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOneHeme Platform
Syndax Pharmaceuticals' (NASDAQ:SNDX) Growing Losses Don't Faze Investors as the Stock Climbs 4.4% This Past Week
Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $34
Syndax Pharmaceuticals Is Maintained at Buy by Citigroup
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $31 to $45
Express News | Syndax Pharmaceuticals Inc : Citigroup Raises Target Price to $34 From $30
Syndax Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
Barclays Maintains Overweight on Syndax Pharmaceuticals, Raises Price Target to $33
Buy Rating Affirmed for Syndax Pharmaceuticals Amid Niktimvo's Promising Market Entry and Efficacy
Sector Update: Health Care Stocks Flat to Higher Premarket Thursday
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $31 to $35
Sector Update: Health Care
Express News | Syndax Pharmaceuticals Inc : BofA Global Research Raises Price Objective to $31 From $30
Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), Arrowhead Pharmaceuticals (ARWR) and Syndax Pharmaceuticals (SNDX)
Express News | Syndax Pharmaceuticals, Inc. : Barclays Raises Target Price to $33 From $32
Analysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Medtronic (MDT)